← Back to screener

MAXLINEAR, INC MXL

Rank #2183 · Nasdaq · $6.0B market cap
Audited by Grant Thornton LLP, no going-concern flag in the latest filing.
Score
30.2
P/E
-82.6
P/B
8.93
ROE
-10.8%
Op. Margin
-5.5%
Debt Ratio
52%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -82.6x, P/B 8.93x. Ranks in the top 74% of the universe.

Profitability ★☆☆☆☆
Weak

ROE -10.8%. Ranks in the top 76% of the universe.

Safety ★★★★☆
Good

Debt ratio 52%. Ranks in the top 24% of the universe.

Growth ★☆☆☆☆
Poor

Revenue decline of 38.1% year over year. Ranks in the top 96% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.0B$0.0B$-0.0B–-569
2012–$0.0B$0.0B$-0.0B–-677
2013–$-0.0B$-0.0B$0.1B–5
2014–$-0.0B$-0.0B$0.1B–34
2015–$-0.0B$-0.0B$0.1B–37
2016–$-0.0B$-0.0B$0.1B–83
2017–$-0.0B$-0.0B$0.1B–71
2018$0.4B$0.1B$0.1B$0.3B16.3166
2019$0.4B$-0.0B$-0.0B$0.4B-5.298
2020$0.4B$-0.0B$-0.0B$0.4B-5.075
2021$0.3B$-0.0B$-0.0B$0.4B-7.0158
2022$0.5B$-0.1B$-0.1B$0.4B-21.1135
2023$0.9B$0.1B$0.0B$0.4B7.3129
2024$1.1B$0.2B$0.1B$0.5B16.181
2025$0.7B$-0.0B$-0.1B$0.7B-5.552

← See the full screener